Copyright
©The Author(s) 2020.
World J Orthop. May 18, 2020; 11(5): 252-264
Published online May 18, 2020. doi: 10.5312/wjo.v11.i5.252
Published online May 18, 2020. doi: 10.5312/wjo.v11.i5.252
Table 2 Antibiotic resistance analysis
| Coagulase-negative Staphylococcus (n = 62) | Enterobacter (n = 3) | Pseudomonas species (n = 10) | |||
| Drug | Resistant (%) | Drug | Resistant (%) | Drug | Resistant (%) |
| Clindamycin | 26 (41.3) | Augmentin | 3 (100) | Augmentin | 9 (90) |
| Erythromycin | 40 (63.5) | Gentamycin | 0 | Amikacin | 1 (10) |
| Levofloxacin | 15 (23.8) | Ceftriaxone | 3 (100) | Aztreonam | 10 (100) |
| Penicillin | 62 (98.4) | Ciprofloxacin | 3 (100) | Imipenem | 9 (90) |
| Clotrimazole | 19 (29.7) | Tetramycin | 3 (100) | Piptazobactam | 0 |
| Tetramycin | 12 (19.0) | Meropenem | 3 (100) | Gentamycin | 0 |
| Oxacillin | 34 (54.0) | Ceftriaxone | 10 (100) | ||
| Tetramycin | 1 (10) | ||||
| Ciprofloxacin | 3 (30) | ||||
| Meropenem | 8 (80) | ||||
- Citation: Qureshi NQ, Mufarrih SH, Irfan S, Rashid RH, Zubairi AJ, Sadruddin A, Ahmed I, Noordin S. Mobile phones in the orthopedic operating room: Microbial colonization and antimicrobial resistance. World J Orthop 2020; 11(5): 252-264
- URL: https://www.wjgnet.com/2218-5836/full/v11/i5/252.htm
- DOI: https://dx.doi.org/10.5312/wjo.v11.i5.252